Skip to main content
. Author manuscript; available in PMC: 2015 May 4.
Published in final edited form as: Can J Cardiol. 2014 Nov 11;31(4):544–547. doi: 10.1016/j.cjca.2014.11.005

Figure 1.

Figure 1

An approach to genetic testing and counselling for symptomatic patients with pulmonary capillary hemochromatosis/pulmonary veno-occlusive disease or with idiopathic or familial pulmonary arterial hypertension (PAH) but not associated PAH. The clinician offers genetic counselling to patients, making them aware of the possibility that they carry a disease-causing mutation and the importance of that knowledge for other family members. The patient may consent to genetic testing, in which case the clinician chooses a test based on the clinical circumstances.